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Amtlortde, an mhtbttor of Na’/H’ exchange. mhtbited down-regulation of protein kinase C in HL60 cells Induced by tumor-promotmg phorbol 
ester in dose-dependent manner judging from tmmunoblot analysts. This inhibition was observed wtth regard to type I (y). type II t/3). and type 
III (a) isozymes of protein kinase C. On the other hand, monensin, a Na’ ionophore, accelerated the down-regulation of protein kmase C Induced 
by phorbol ester. When we examined “Na’ uptake by HL60 cells, the higher uptake was observed after stimulation with phorbol ester compared 
to the control cells and thts “Na’ uptake was strongly rnhibtted by the addition of amtlortde. However. monensin further sttmulated the “Na’ 
uptake observed in phorbol ester-treated cells, These data suggest that the mcrease in intracellular Na’ concentratton may be one of the triggers 
for the mductton of down regulation of protem kmase C. 
Protein kmase C; Down-reguiatton, Na’lH’ exchanger; HL60 cell 
1. INTRODUCTION brane at the initial stage of cellular proliferation, such 
as regenerating rat liver [ 11,123. 
It has been shown that ion channels such as Na+/H’ In the previous reports from our laboratory, it was 
exchanger in plasma membrane are activated by various shown that protease-activated form of PKC (protein 
external signals such as hormones. growth factors and kinase Ml was released from rat liver plasma membrane 
tumor-promoting phorbol esters and activation of these under slightly higher ionic strength than physiological 
systems is involved in control of intracellular pH and level and alkaline pH [13,14]. So we studied the effects 
Na+ concentration [l-5]. In addition, it has been also of some drugs which change intracellular Na’ concen- 
proposed that intracellular Na’ increase or pH eleva- tration on PKC down regulation using TPA-stimulated 
tion is important at the initial stage of cell growth [I ,2]. HL60 cells. 
On the other hand, it has been well established that 
protein kinase C (PKC) plays a central role in various 
metabolic regulations induced by receptor-mediated hy- 
drolysis of inositol phospholipids [6]. It has been also 
established that PKC is distributed in various mammal- 
ian tissues, mainly in their cytosolic fraction [7,X]. When 
various cells are stimulated with tumor-promoting 
phorbol esters such as 12-O-tetradecanoyl-phorbol 13- 
acetate (TPA), cytosolic PKC is translocated to plasma 
membrane and activated, then subjected to proteolytic 
attacks [9,10]. Moreover, it has been reported that rat 
liver PKC is activated and translocated to plasma mem- 
2. MATERIALS AND METHODS 
2.1. Materids and chenuds 
“NaCl (905 mCt/mg) and a monoclonal anti-PKC anttbody desig- 
nated MC-S (code RPN. 536) were purchased from Amersham. RPM1 
1640 culture medtum and fetal bovine serum were purchased from 
Gibco. TPA, ouabam. amiloride. and monensm were from Sigma 
Monoclonal anti-type I (y), anti-type II @), and anti-type III (a) PKC 
antibodies designated MC-la. MC-2a, and MC-3a. respecttvely, were 
from Seikagaku Kogyo Corp. 
Correspondence address H. Yamamura, Departments of Biochem- 
istry, Fukui Medical School, Matsuoka. Fukui. 910-I 1, Japan. Fax: 
(81) (776) 61-8102. 
Abbrevmrions: PKC, protein kinase C: TPA. 12-O-tetradecanoyl- 
phorbol 13-acetate; SDS-PAGE. sodium dodecyl sulfate-poly- 
acrylamtde gel electrophoresis; TPBS, phosphate-buffered saline con- 
taimng 0.05% Tween 20. 
Human promyeiocytlc leukemia cell hne HL60 cells were grown in 
RPM1 1640 medium supplemented with 5% fetal bovme serum, 0 12 
mgiml kanamycm at 37OC in a humidi~ed atmosphere containmg 5% 
CO,. Cells in the exponential growth phase were used. Down regula- 
tion of PKC was induced by addition of 400 nM TPA. Amtloride and 
monensm were added 30 min before mittatton of each experiment 
except “Na’ uptake experrments. All assay mediums contained 1 mM 
ouabam to block Na”/K’ ATPase activtty. 
2.3. Preparation ot‘protern kuwxe C 
HL60 cells (1 x IOR cells) were harvested by centrifugation. and 
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washed twice, then the cell pellet was resuspended m I ml of Buffer 
A (20 mM Tris-HCI at pH 7.5 containing 0.25 M sucrose, I mM 
ethylene glycol his@-aminoethylether)-N.N,N’,N’-tetraacetic acid, 1 
mM EDTA. 1 mM phenylmethylsulfonyl fluoride and 0.4 mM le- 
upeptin). The cells were homogenized by 60 strokes with a Dounce 
homogenizer. The homogenate was centrifuged for 10 min at 
1,500 x g, and the supernatant was further centrifuged for 60 min at 
100,000 x g. The supernatant was employed as the enzyme derived 
from the cytosolic fraction of HL60 cells. The pellet obtained by 
centrifugatton at 100,000 x g was resuspended m Iml of Buffer A 
containing 1% (v/v) Triton X-100, and homogenized by 60 strokes 
with a Dounce homogenizer. The homogenate was stirred at 0°C for 
30 min, then the solubilized sample was sonicated using a Tomy 
UD-200 ultrasonic disrupter (three 15-s bursts), and centrifuged for 
40 min at 100,000 x g. The supernatant was employed as the enzyme 
derived from the particulate fraction of HL60 cells, 
2.4. Immunoblot analysts 
PKC prepared as described above were separated usmg 10% sodium 
dodecyl sulfate-polyacrylamide gel electrophorests (SDS-PAGE) [l5]. 
Immunoblot analysis was carried out as described previously [16]. 
Nitrocellulose membrane was reacted with each antibody. The con- 
centrations of the monoclonal antibodies were approximately 1 ,ug/ml 
m the presence of I mg/ml bovine serum albumin m phosphate-buff- 
ered saline containing 0.05% Tween 20 (TPBS). Mouse immunoglob- 
ulm was then reacted with biotin-conlugated rabbit anti-mouse immu- 
noglobulins diluted 1 : 500 in TPBS and then with avidin-conjugated 
perowidase diluted 1 : 500 m TPBS. Densitometoric analyses were 
performed using Scanning Densitometer GS 300 (Hoefer Scientific 
Instruments). 
2.5. “Na’ uptake experiments 
I fiCi/ml “Na’ was added to HL60 cells suspended at I x IO’ cells/ 
ml in RPM1 1640 medium supplemented with 15% fetal bovine serum 
and allowed to equilibrate for I5 mm at 37°C. At various ttmes after 
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the additton of drugs (TPA, amiloride, monensm, and ouabain), 0.5 
ml aliquots (5 x I O6 cells) were removed and placed m I .5 ml microfuge 
tubes containing 0.3 ml of denonylphthalate/sihcon oil (I :I). and cen- 
trifuged at 12,000 rpm for 20 s [l7]. The supernatants were removed 
and washed with 0.5 ml of cold phosphate-buffered saline. The cell 
pellets were harvested into 0.1 ml of 0.1 N NaOH and the radioactiv- 
ities present in the pellets were directly counted for “Na’ using a 
gamma spectrometer (Aloka. ARC-2000). 
2.6. Protein determmations 
Protein was determined by the method of Bradford 1181 with bovine 
serum albumin as a standard. 
3. RESULTS 
It has been well known that TPA induces down regu- 
lation of PKC [9,10]. As shown in Fig. lA, TPA-in- 
duced degradation of PKC was observed within 60 min 
in both cytosolic and particulate fractions of HL60 cells. 
At 120 min after stimulation with TPA, PKC was 
faintly detected in cytosolic fraction, although it re- 
mained slightly in particulate fraction. 
Amiloride, which is an inhibitor of Na’/H’ ex- 
changer, is known to inhibit intracellular Na’ influx and 
cytoplasmic alkalinization [19]. We examined the effect 
of amiloride on PKC down regulation promoted by 
TPA in HL60 cells. Fig. 1B shows that in the presence 
of amiloride, PKC was detected in both cytosolic and 
particulate fractions of HL60 cells until 120 min after 
the stimulation with TPA. This result indicates that 
amiloride inhibited PKC down regulation promoted by 
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Fig. I Effect of amiloride on PKC down-regulation in HL60 cells. HL60 cells were incubated with 400 nM TPA for indicated times in the absence 
(A) or presence (B) of 0.1 mM amiloride. The samples derived from HL60 cells were prepared as described in section 2. (a) 100 pg of cytosolic 
proteins and (b) 40 fig of particulate protems were employed for immunoblot analyses with anti-PKC antibody (MC-5). Numbers with arrows 
indicate the molecular mass markers (K, kDa), phosphorylase b (94 kDa). bovine serum albumin (67 kDa), ovalbumm (43 kDa) and carbonic 
anhydrase (30 kDa). The arrowheads indicate the position of PKC. Incubation times of HL60 cells with TPA were as follows: lane I, 0 min; 
lane 2, 60 min; lane 3. 120 mm. 
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Fig. 2. Dose-dependent inhibitory effect of amtloride on PKC down-regulatton m HL60 cells. HL60 cells were incubated with 400 nM TPA m the 
presence of various concentrations of amiloride for 60 min, then the samples derived from HL60 cells were prepared as described m section 2. (a) 
100 pg of cytosolic proteins and (b) 40 pg of particulate proteins were employed for immunoblot analyses with antt-PKC anttbody (MC-5) The 
arrowheads indicate the position of PKC. Lane 1, control cells. Amilortde concentrations were as follows: lane 2, 0 FM; lane 3, 1 PM; lane 4, 
10 ,uM; lane 5, 100 PM; lane 6, 200 PM. 
TPA. Fig. 2 shows that amiloride inhibited PKC down 
regulation in dose-dependent manner in both cytosolic 
and particulate fractions of HL60 cells. When we exam- 
ined the effect of this drug on PKC isozymes using 
anti-type I (y). anti-type II @). and anti-type III (a) 
PKC antibodies, amiloride inhibited the down regula- 
tion of all of three PKC isozymes (Table I). So we 
supposed that this inhibitory effect of amiloride on PKC 
down-regulation might be caused by interfering with 
intracellular Na’ influx or pH elevation in HL60 cells. 
In the next experiments, we examined the effect of 
monensin, a Na’ ionophore which can induce the eleva- 
tion of intracellular Na’ concentration, on PKC down- 
regulation promoted by TPA in HL60 cells. As shown 
in Fig. 3, in the presence of monensin PKC was not 
detected at 30 min after the stimulation by TPA in both 
cytosolic and particulate fractions of HL60 cells. al- 
though PKC was still detected at that time after the 
stimulation by TPA in the absence of monensin. This 
result suggests that monensin accelerated PKC down 
regulation promoted by TPA. PKC isozyme experi- 
A (a) 
0 30 60 min 
f 
ments also showed that monensin accelerated the down 
regulation of all of type I (y), type II (B). and type III 
(a) PKC (data not shown). These results suggest that 
the increase in intracellular Na’ concentration seems to 
be important for PKC down regulation. 
In the last experiments, we examined the correlation 
between “Na+ uptake by HL60 cells and PKC down- 
regulation in the presence of various drugs employed 
above (Fig. 4). “Na’ uptake in phorbol ester-treated 
cells was constantly higher than that of control cells and 
the extent of stimulation in this “Na’ uptake was simi- 
lar to that previously reported [4]. However, amiloride 
strongly inhibited the “Na+ uptake detected in phorbol 
ester-stimulated cells. In contrast, monensin further ac- 
celerated the “Na’ uptake observed with the treatment 
by phorbol ester. In correspondence to the changes in 
“Na+ uptake, PKC down-regulation induced by TPA 
was strongly inhibited by amiloride. but accelerated by 
monensin in both cytosolic and particulate fractions. 
These results strongly suggest that the down-regulation 
of PKC is correlated with the Na+ influx. 
UN 
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Fig. 3. Effect of monensin on PKC down-regulation in HL60 cells. HL60 cells were incubated with 400 nM TPA for indicated times in the absence 
(A) or presence (B) of20pg/ml of monensm, then the samples derived from HL60 cells were prepared as descrrbed in section 2. (a) 1OOpg of cytosolic 
proteins and (b) 40 pg of particulate protems were employed for immunoblot analyses with anti-PKC anttbody (MC-5). The arrowheads indrcate 
the position of PKC. Incubation times of HL60 cells with TPA were as follows: lane 1, 0 min; lane 2. 30 min; lane 3, 60 min. 
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Fig. 4. Effect of amiloride and monensm on TPA-induced “Nat uptake and PKC down-regulation m HL 60 cells. HL60 cells equilibrated with 
“Na’ were incubated with 400 nM TPA for indicated times in the absence or presence of 0.1 mM amiloride or 2O&ml monensin, then intracellular 
“Na’ was counted using a gamma-counter as described in section 2 (A). HL60 cells were also Incubated with 400 nM TPA for indicated times 
m the absence or presence of 0.1 mM amiloride or 20 &ml monensin. then the samples derived from HL 60 cells were prepared as described in 
section 2. One-hundred pg of cytosolic proteins (B) and 40 pg of particulate proteins (C) were employed for immunoblot analyses with anti-PKC 
antibody (MC-5). then the PKC bands were subjected to densitometric analyses as described in section 2. The results represent percentages takmg 
that at 0 time as 100%. A typical result from two independent experiments was presented. (0) None (control); (0) TPA; (0) TPA + amiloride; 
(m) TPA + monensin. 
4. DISCUSSION 
In this report, we showed that amiloride, an inhibitor 
of Na’/H’ exchanger, inhibited PKC down-regulation 
promoted by TPA in HL60 cells, but monensin, a Na’ 
ionophore, accelerated it. Amiloride decreased intracel- 
lular “Na+concentration in TPA-treated HL60 cells, 
Table I 
Effect of amiloride on down-regulation of PKC isozymes in HL60 cells 
Subtype Amiloride Fraction Relative amount of PKC (%) 
0 min 60 min 120 min 
I - cytosolic 100 14 9 
- particulate 100 28 23 
+ cytosolic 100 II 62 
+ particulate 100 81 85 
II _ cytosolic 100 18 32 
- particulate 100 32 23 
+ cytosolic 100 78 65 
+ particulate 100 95 69 
III - cytosolic 100 53 21 
- particulate 100 56 29 
+ cytosolic 100 96 88 
+ particulate 100 87 72 
HL60 cells were incubated with 400 nM TPA for indicated times m 
the absence or presence of 0.1 mM amiloride. The samples derived 
from HL60 cells were prepared as described in section 2. One-hundred 
fig of cytosolic proteins and 40 pg of particulate proteins were em- 
ployed for immunoblot analyses with anti-type I (y), anti-type II (B). 
and anti-type III (a) PKC antibodies then the PKC bands were sub- 
jected to densitometric analyses as described m section 2. The results 
represent relative amounts of PKC taking that at 0 min in each exper- 
iments as 100%. A typical result from two independent experiments 
was presented. 
but monensin increased it. These results strongly sug- 
gest that the changes in intracellular Na’ concentration 
are important for PKC down regulation. The PKC 
bands recognized by the monoclonal anti-PKC anti- 
body (MC-5) were often shown as double bands. We 
supposed that some modifications such as phosphoryla- 
tion changed their mobilities on SDS-PAGE as previ- 
ously described [20]. 
It has been well known that PKC is activated by 
receptor-mediated hydrolysis of inositol phospholipids 
induced by various external signals such as hormones, 
neurotransmitters and some growth factors and plays 
important roles in controlling many cellular functions 
and proliferation [6]. It has been also shown that Na’l 
H’ exchanger is activated by various external signals 
such as hormones, growth factors and TPA [ ll5]. There 
have been many reports suggesting that PKC phospho- 
rylates and activates Na+/H’ exchanger in plasma mem- 
brane of various mammalian cells and these events 
cause increase in intracellular Na’ concentration and 
cytoplasmic alkalinization [4,5,21]. This increase in in- 
tracellular Na’ concentration and alkalinization are 
thought to be important at the initial stage of cell 
growth but their physiological meanings are still un- 
known [ 1,2]. 
We suppose that this increase in intracellular Na’ 
concentration and alkalinization may affect the prote- 
olytic degradation of PKC. Indeed, our previous re- 
ports indicated that PKC was easily subjected to prote- 
olytic attacks under slightly higher ionic strength than 
physiological level and alkaline pH in vitro [13,14]. In 
this study, we presented the evidence suggesting that the 
increase in intracellular Na’ concentration may induce 
PKC down regulation in HL60 cells. Further studies 
seem to be necessary for full understanding the role of 
283 
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activation of Na’/H’ exchanger in the process of cell 
proliferation including the mechanism of down regula- 
tion of PKC. 
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